Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by facility in the most recent years of data available.

Number of patients (n) and relative percentages (%) of patients according to age and total T serum levels.

Vincenzo Rochira (337855)
Lucia Zirilli (337857)
Gabriella Orlando (337858)
Daniele Santi (337859)
Giulia Brigante (337860)
Chiara Diazzi (337861)
Federica Carli (337862)
Cesare Carani (337863)
Giovanni Guaraldi (295135)

February 2013

Number of patients (n) and relative percentages (%) of patients according to age an...

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years of follow up on ART.

Barbara Castelnuovo (10700)
Agnes Kiragga (293779)
Joseph Musaazi (834535)
Joseph Sempa (455277)
Frank Mubiru (834536)
Jane Wanyama (834537)
Bonnie Wandera (736998)
Moses Robert Kamya (834538)
Andrew Kambugu (166978)

December 2015

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years...

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on varying population INHR-TB prevalence.

Kamila Romanowski (6260870)
Jonathon R. Campbell (4543495)
Olivia Oxlade (66115)
Federica Fregonese (442412)
Dick Menzies (66118)
James C. Johnston (370579)

January 2019

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...

Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by year of treatment initiation.

Herbert C. Duber (712085)
Emily Dansereau (610260)
Samuel H. Masters (673005)
Jane Achan (145106)
Roy Burstein (673006)
Brendan DeCenso (673007)
Anne Gasasira (232652)
Gloria Ikilezi (673010)
Caroline Kisia (673011)
Felix Masiye (344814)
Pamela Njuguna (357242)
Thomas Odeny (712086)
Emelda Okiro (712087)
D. Allen Roberts (712088)
Emmanuela Gakidou (250582)

March 2015

Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by year of treatment initiation....

Median CD4 (IQR) for patients initiated on ART, by adherence < or ≥95% based on drug-refill visits.

Ziad El-Khatib (354831)
David Katzenstein (182035)
Gaetano Marrone (239053)
Fatima Laher (238017)
Lerato Mohapi (158544)
Max Petzold (177356)
Lynn Morris (7883)
Anna Mia Ekström (102696)

February 2013

Median CD4 (IQR) for patients initiated on ART, by adherence < or ≥95...

Market share of AZT, TDF and TAF in first-line treatment from 2015 to 2025.

Aastha Gupta (681328)
Sandeep Juneja (3220047)
Marco Vitoria (183846)
Vincent Habiyambere (523965)
Boniface Dongmo Nguimfack (3220050)
Meg Doherty (482820)
Daniel Low-Beer (229217)

October 2016

Market share of AZT, TDF and TAF in first-line treatment from 2015 to 2025.</p

Percentage of ART patients at each intervention facility who received ARVs at home.

Pascal Geldsetzer (549621)
Joel M. Francis (804220)
David Sando (3234492)
Gerda Asmus (5770376)
Irene A. Lema (5770379)
Eric Mboggo (3774367)
Happiness Koda (3774373)
Sharon Lwezaula (3774385)
Ramya Ambikapathi (5770382)
Wafaie Fawzi (538642)
Nzovu Ulenga (3774370)
Till Bärnighausen (36281)

September 2018

Percentage of ART patients at each intervention facility who received ARVs at home.</p

Percentage of patients with various TSAT levels in the last 3 months of three studies over 14 years from 1997 to 2011.

Jonathan A. Lorch (566667)
Victor E. Pollak (566668)

May 2014

Percentage of patients with various TSAT levels in the last 3 months of three studies over 14 yea...

Percentage of correctly classified BD Vacutainer CD4 Stabilization Tube sample results on BD FacsCount for ART eligibility thresholds of 350 and 500 CD4 cells/μL over time with EDTA tube results on FacsCount at day 0 as reference methodology.

Florian Vogt (756416)
Rafael Van den Bergh (113711)
Andrea Bernasconi (80983)
Buhlebenkosi Moyo (756418)
Liberty Havazvidi (756419)
Mathieu Bastard (109538)
Laurence Flevaud (295473)
Fabian Taziwa (418345)
Eliphas Makondo (756417)
Sekesai Mtapuri-Zinyowera (785978)

August 2015

ART: Anti-retroviral therapy. CD4: Cluster of Differentiation Type 4. CI: Confidence Interval.</p...

Percentage of patients P% with indices , , and within tolerance levels for different treatment sites (breast, thorax, abdomen, pelvis, and H&N) and techniques (IMRT and VMAT).

Jie Li (15030)
Angelo Piermattei (835809)
Pei Wang (102036)
Shengwei Kang (4846735)
Mingyong Xiao (4846738)
Bin Tang (56654)
Xiongfei Liao (4846726)
Xin Xin (232416)
Mattia Grusio (4846729)
Lucia Clara Orlandini (4846732)

February 2018

Percentage of patients P% with indices , , and within tolerance levels for different treatment s...

Proportion of antiretroviral therapy (ART) initiation among patients attending HIV clinics in two U.S. cities as measured by ART prescriptions written before or within 7 days after index visit, August 1, 2015-March 31, 2017, by selected patient characteristics.

Mary Spink Neumann (5824034)
Aaron Plant (5433278)
Andrew D. Margolis (130004)
Craig B. Borkowf (226185)
C. Kevin Malotte (271544)
Cornelis A. Rietmeijer (5824037)
Stephen A. Flores (243186)
Lydia O’Donnell (5824040)
Susan Robilotto (5824043)
Athi Myint-U (5824046)
Jorge A. Montoya (5433272)
Marjan Javanbakht (3857254)
Jeffrey D. Klausner (307922)

October 2018

Proportion of antiretroviral therapy (ART) initiation among patients attending HIV clinics in two U....

Market share of AZT, TDF, TAF and DTG in second-line treatment from 2015 to 2025.

Aastha Gupta (681328)
Sandeep Juneja (3220047)
Marco Vitoria (183846)
Vincent Habiyambere (523965)
Boniface Dongmo Nguimfack (3220050)
Meg Doherty (482820)
Daniel Low-Beer (229217)

October 2016

Market share of AZT, TDF, TAF and DTG in second-line treatment from 2015 to 2025.</p

Proportion of patients on ART at 12 months: comparison of estimates according to the sampling technique (median, inter-quartile range, 10–90% deciles and minimum maximum) with the unsampled value (dotted line).

Jean-Michel Tassie (359923)
Karen Malateste (359924)
Mar Pujades-Rodríguez (5648761)
Elisabeth Poulet (359925)
Diane Bennett (32530)
Anthony Harries (328743)
Mary Mahy (359926)
Mauro Schechter (4928)
Yves Souteyrand (183850)
François Dabis (78475)

February 2013

Proportion of patients on ART at 12 months: comparison of estimates according to the sampling tec...

Description of ART usage among 371 women who initiated treatment.

Eugene Mutimura (239330)
Donald R. Hoover (111760)
Qiuhu Shi (239318)
Jean Claude Dusingize (473718)
Jean D’Amour Sinayobye (725110)
Mardge Cohen (235024)
Kathryn Anastos (119435)

April 2015

Proportions of HIV+ ART initiators: 26.7% used AZT, 62.5% used D4T, 89.1% used NRTI total and 1.3...

The proportion of participants with the respective number of dispensed medications among patients with chronic disease at UoGCSH, 2021.

Eyayaw Ashete Belachew (13840796)
Ashenafi Kibret Sendekie (12646960)
Samuel Agegnew Wondm (14420056)
Emneteab Mesfin Ayele (14420059)
Adeladlew Kassie Netere (4621486)

January 2023

The proportion of participants with the respective number of dispensed medications among patients wi...

Number of patients (n) and relative percentages (%) of patients according to age and total T serum levels.

Vincenzo Rochira (337855)
Lucia Zirilli (337857)
Gabriella Orlando (337858)
Daniele Santi (337859)
Giulia Brigante (337860)
Chiara Diazzi (337861)
Federica Carli (337862)
Cesare Carani (337863)
Giovanni Guaraldi (295135)

February 2013

Number of patients (n) and relative percentages (%) of patients according to age an...

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years of follow up on ART.

Barbara Castelnuovo (10700)
Agnes Kiragga (293779)
Joseph Musaazi (834535)
Joseph Sempa (455277)
Frank Mubiru (834536)
Jane Wanyama (834537)
Bonnie Wandera (736998)
Moses Robert Kamya (834538)
Andrew Kambugu (166978)

December 2015

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years...

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on varying population INHR-TB prevalence.

Kamila Romanowski (6260870)
Jonathon R. Campbell (4543495)
Olivia Oxlade (66115)
Federica Fregonese (442412)
Dick Menzies (66118)
James C. Johnston (370579)

January 2019

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...

Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by year of treatment initiation.

Herbert C. Duber (712085)
Emily Dansereau (610260)
Samuel H. Masters (673005)
Jane Achan (145106)
Roy Burstein (673006)
Brendan DeCenso (673007)
Anne Gasasira (232652)
Gloria Ikilezi (673010)
Caroline Kisia (673011)
Felix Masiye (344814)
Pamela Njuguna (357242)
Thomas Odeny (712086)
Emelda Okiro (712087)
D. Allen Roberts (712088)
Emmanuela Gakidou (250582)

March 2015

Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by year of treatment initiation....

Median CD4 (IQR) for patients initiated on ART, by adherence < or ≥95% based on drug-refill visits.

Ziad El-Khatib (354831)
David Katzenstein (182035)
Gaetano Marrone (239053)
Fatima Laher (238017)
Lerato Mohapi (158544)
Max Petzold (177356)
Lynn Morris (7883)
Anna Mia Ekström (102696)

February 2013

Median CD4 (IQR) for patients initiated on ART, by adherence < or ≥95...

Market share of AZT, TDF and TAF in first-line treatment from 2015 to 2025.

Aastha Gupta (681328)
Sandeep Juneja (3220047)
Marco Vitoria (183846)
Vincent Habiyambere (523965)
Boniface Dongmo Nguimfack (3220050)
Meg Doherty (482820)
Daniel Low-Beer (229217)

October 2016

Market share of AZT, TDF and TAF in first-line treatment from 2015 to 2025.</p

Percentage of ART patients at each intervention facility who received ARVs at home.

Pascal Geldsetzer (549621)
Joel M. Francis (804220)
David Sando (3234492)
Gerda Asmus (5770376)
Irene A. Lema (5770379)
Eric Mboggo (3774367)
Happiness Koda (3774373)
Sharon Lwezaula (3774385)
Ramya Ambikapathi (5770382)
Wafaie Fawzi (538642)
Nzovu Ulenga (3774370)
Till Bärnighausen (36281)

September 2018

Percentage of ART patients at each intervention facility who received ARVs at home.</p

Percentage of patients with various TSAT levels in the last 3 months of three studies over 14 years from 1997 to 2011.

Jonathan A. Lorch (566667)
Victor E. Pollak (566668)

May 2014

Percentage of patients with various TSAT levels in the last 3 months of three studies over 14 yea...

Percentage of correctly classified BD Vacutainer CD4 Stabilization Tube sample results on BD FacsCount for ART eligibility thresholds of 350 and 500 CD4 cells/μL over time with EDTA tube results on FacsCount at day 0 as reference methodology.

Florian Vogt (756416)
Rafael Van den Bergh (113711)
Andrea Bernasconi (80983)
Buhlebenkosi Moyo (756418)
Liberty Havazvidi (756419)
Mathieu Bastard (109538)
Laurence Flevaud (295473)
Fabian Taziwa (418345)
Eliphas Makondo (756417)
Sekesai Mtapuri-Zinyowera (785978)

August 2015

ART: Anti-retroviral therapy. CD4: Cluster of Differentiation Type 4. CI: Confidence Interval.</p...

Percentage of patients P% with indices , , and within tolerance levels for different treatment sites (breast, thorax, abdomen, pelvis, and H&N) and techniques (IMRT and VMAT).

Jie Li (15030)
Angelo Piermattei (835809)
Pei Wang (102036)
Shengwei Kang (4846735)
Mingyong Xiao (4846738)
Bin Tang (56654)
Xiongfei Liao (4846726)
Xin Xin (232416)
Mattia Grusio (4846729)
Lucia Clara Orlandini (4846732)

February 2018

Percentage of patients P% with indices , , and within tolerance levels for different treatment s...

Proportion of antiretroviral therapy (ART) initiation among patients attending HIV clinics in two U.S. cities as measured by ART prescriptions written before or within 7 days after index visit, August 1, 2015-March 31, 2017, by selected patient characteristics.

Mary Spink Neumann (5824034)
Aaron Plant (5433278)
Andrew D. Margolis (130004)
Craig B. Borkowf (226185)
C. Kevin Malotte (271544)
Cornelis A. Rietmeijer (5824037)
Stephen A. Flores (243186)
Lydia O’Donnell (5824040)
Susan Robilotto (5824043)
Athi Myint-U (5824046)
Jorge A. Montoya (5433272)
Marjan Javanbakht (3857254)
Jeffrey D. Klausner (307922)

October 2018

Proportion of antiretroviral therapy (ART) initiation among patients attending HIV clinics in two U....

Market share of AZT, TDF, TAF and DTG in second-line treatment from 2015 to 2025.

Aastha Gupta (681328)
Sandeep Juneja (3220047)
Marco Vitoria (183846)
Vincent Habiyambere (523965)
Boniface Dongmo Nguimfack (3220050)
Meg Doherty (482820)
Daniel Low-Beer (229217)

October 2016

Market share of AZT, TDF, TAF and DTG in second-line treatment from 2015 to 2025.</p

Proportion of patients on ART at 12 months: comparison of estimates according to the sampling technique (median, inter-quartile range, 10–90% deciles and minimum maximum) with the unsampled value (dotted line).

Jean-Michel Tassie (359923)
Karen Malateste (359924)
Mar Pujades-Rodríguez (5648761)
Elisabeth Poulet (359925)
Diane Bennett (32530)
Anthony Harries (328743)
Mary Mahy (359926)
Mauro Schechter (4928)
Yves Souteyrand (183850)
François Dabis (78475)

February 2013

Proportion of patients on ART at 12 months: comparison of estimates according to the sampling tec...

Description of ART usage among 371 women who initiated treatment.

Eugene Mutimura (239330)
Donald R. Hoover (111760)
Qiuhu Shi (239318)
Jean Claude Dusingize (473718)
Jean D’Amour Sinayobye (725110)
Mardge Cohen (235024)
Kathryn Anastos (119435)

April 2015

Proportions of HIV+ ART initiators: 26.7% used AZT, 62.5% used D4T, 89.1% used NRTI total and 1.3...

The proportion of participants with the respective number of dispensed medications among patients with chronic disease at UoGCSH, 2021.

Eyayaw Ashete Belachew (13840796)
Ashenafi Kibret Sendekie (12646960)
Samuel Agegnew Wondm (14420056)
Emneteab Mesfin Ayele (14420059)
Adeladlew Kassie Netere (4621486)

January 2023

The proportion of participants with the respective number of dispensed medications among patients wi...

Number of patients (n) and relative percentages (%) of patients according to age and total T serum levels.

Vincenzo Rochira (337855)
Lucia Zirilli (337857)
Gabriella Orlando (337858)
Daniele Santi (337859)
Giulia Brigante (337860)
Chiara Diazzi (337861)
Federica Carli (337862)
Cesare Carani (337863)
Giovanni Guaraldi (295135)

February 2013

Number of patients (n) and relative percentages (%) of patients according to age an...

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years of follow up on ART.

Barbara Castelnuovo (10700)
Agnes Kiragga (293779)
Joseph Musaazi (834535)
Joseph Sempa (455277)
Frank Mubiru (834536)
Jane Wanyama (834537)
Bonnie Wandera (736998)
Moses Robert Kamya (834538)
Andrew Kambugu (166978)

December 2015

Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years...

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on varying population INHR-TB prevalence.

Kamila Romanowski (6260870)
Jonathon R. Campbell (4543495)
Olivia Oxlade (66115)
Federica Fregonese (442412)
Dick Menzies (66118)
James C. Johnston (370579)

January 2019

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...

Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by facility in the most recent years of data available.

Abstract

Extracted data

Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by facility in the most recent years of data available.

Abstract

Extracted data

Related items

Related items